As of July 2026, 55 paid clinical trials are recruiting in Clackamas, Oregon. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Clackamas offers studies at sites including Clackamas Radiation Oncology Center for conditions such as Malignant Solid Neoplasm, Metastatic Melanoma, Prostate Adenocarcinoma, Stage III Laryngeal Cancer AJCC v8. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Researchers run research studies in Clackamas, OR at 10 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Clackamas Radiation Oncology Center | Malignant Solid Neoplasm, Metastatic Melanoma, Prostate Adenocarcinoma | 44 |
| Providence Cancer Institute Clackamas Clinic | Acral Lentiginous Melanoma, Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 | 5 |
| Kaiser Permanente Sunnyside Medical Center | Atherosclerotic Cardiovascular Disease (ASCVD), Colonic Diseases, Colorectal Neoplasms | 3 |
| Kaiser Sunnyside Medical Center | Breast Cancer, Cutaneous Melanoma, Stage II, Metastatic Clear Cell Renal Cell Carcinoma | 3 |
| Enveda Investigative Site | Asthma | 1 |
| Kaiser Permanente | High-Risk Percutaneous Coronary Intervention (High-risk PCI) | 1 |
| Kaiser Permanente Northwest | Aortic Stenosis, Coronary Artery Disease, Coronary Stenosis | 1 |
| Kaiser Portland | Aortic Stenosis, Severe | 1 |
| Kymera Investigative Site | Eosinophilic Asthma | 1 |
| Portland Allergy and Asthma | Chronic Spontaneous Urticaria | 1 |
Recruiting trials in Clackamas grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
There are approximately 55 recruiting clinical trials in Clackamas, Oregon listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Clackamas compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Clackamas include Malignant Solid Neoplasm (3), Metastatic Melanoma (3), Prostate Adenocarcinoma (3), Stage III Laryngeal Cancer AJCC v8 (3), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Clackamas on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Clackamas include Clackamas Radiation Oncology Center, Providence Cancer Institute Clackamas Clinic, Kaiser Permanente Sunnyside Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Clackamas are Cancer & tumors (38), Cardiovascular (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.